Labroots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7th Annual Event in the Microbiology Week Virtual Event Series, held on September 7-9, 2021!
Microbiology Week Virtual Event Series 2021 will offer a 3-day content-rich program offering invited lectures, thought-provoking discussions and posters to explore global developments for the prevention, diagnosis, and treatment of Infectious Diseases, discoveries in Microbiology & Immunology research to improve human, animal, and plant health, including virology, pathogenesis, genomics and epidemiology, microbial communities and biofilms, and research to find improved vaccines, diagnostics, and antiviral drugs for Influenza.
This year's event includes the following topics and tracks:
Immunology:
Infectious Disease:
Respiratory Viruses:
Microbial Communities:
Modeling Approaches:
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Microbiology Virtual Week. Submit your free abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Continuing Education - Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits.
Use #LRmicro to follow the conversation!
Founder and Epidemiologist, Infectious Economics, LLC
Vice President of Research and Development, Jumpcode Genomics
Head of the Microbiology and Immunology Research Program, Children's Cancer Hospital of Egypt; Professor, Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University
Professor, Department of Molecular Genetics, The Ohio State University
R&D Scientist at MilliporeSigma
Associate Professor, Depts of Surgery and Laboratory Medicine and Pathology, Bernard and Edith Waterman Co-Director, Microbiome Program, Mayo Clinic
Chief Technology Officer, Biotia, Inc.
Distinguished Professor, Department of Microbiology & Plant Pathology, Institute for Integrative Genome Biology, University of California, Riverside
Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
Chief, Division of Infectious Disease - at OPTUM TriState, Clinical Instructor of Medicine - Columbia University College of Physicians and Surgeons, Department of Medicine-Division of Infectious Diseases
Associate Professor in the Department of Microbiology and Plant Pathology in the College of Natural and Agricultural Sciences at the University of California, Riverside
Assistant Professor, Department of Molecular Genetics and Microbiology, Duke University School of Medicine
Director of Bioinformatics, Center for Infection Immunity, Columbia University Irving Medical Center
Professor, Molecular Microbiology and Immunology, University of Missouri School of Medicine
Professor of Biomedical Sciences and Co-Director at the UCR Aging Initiative, University of California Riverside
Professor, Department of Molecular Microbiology & Immunology, Biochemistry & Molecular Biology and International Health, John Hopkins Bloomberg School of Public Health, Co-director, Center for Women's Health, Sex, and Gender Research
Assistant Professor, Department of Internal Medicine: Infectious Diseases Section, Yale University School of Medicine
Professor of Otolaryngology, Pathology Dermatology, University of Colorado School of Medicine; Founder, President, and CSO, Summit Biolabs, Inc.
Professor, Department of Plant Pathology, University of Kentucky
Associate Professor, The RNA Institute, University at Albany, SUNY
Director, Clinical Microbiology, Professor, Clinical Pathology, The Ohio State University Wexner Medical Center
Associate Professor, Department of Medicine, Director, Center for Virus-Host-Innate Immunity (CVHII), Institute for Infectious and Inflammatory Diseases, Rutgers University, New Jersey Medical School Cancer Center
Area Coordinator-Microbiology, HAZMAT, and Disaster Preparedness for Riverview Health in Noblesville, Indiana
R&D Scientist at MilliporeSigma
Senior Research Scientist, Summerland Research and Development Centre of Agriculture and Agri-Food Canada
Professor of Microbiology and Immunology, University of Rochester Medical School, David H. Smith Center for Vaccine Biology and Immunology
Assistant Professor of Epidemiology, Columbia University
Co-director of the Coronavirus Laboratory The National Center of Biotechnology
Associate Professor in the Programme in Emerging Infectious Diseases, Duke-NUS Medical School
Research Plant Pathologist, USDA-ARS Foreign Disease-Weed Science Research Unit, Frederick, Maryland
Professor of Microbiology and Civil, Environmental and Geodetic Engineering; Gordon and Betty Moore Foundation Investigator; Co-director | OSU Infectious Diseases Institute Microbial...
Co-Founder, Human Microbiology Institute
Director, Flow Cytometry Assays & Application
Professor, Department of Microbiology and Immunology, Stanford University School of Medicine
Assistant Professor of Biostatistics, Johns Hopkins University
Sino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers ...
See moreABSA International (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. Its goals are to provide a professional association that represents the interests and needs of practitioners ...
See moreAt Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic ...
See moreThermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving ...
See moreFor 60 years The Baker Company has been at the forefront of engineering, testing and production of reliable laboratory contamination control equipment. Recognized as the industry pioneer, The Baker Company maintains an unparalleled passion for helping our customers advance ...
See moreAnalytik Jena is a provider of instruments and products in the areas of analytical measuring technology and life science. Its portfolio includes the most modern analytical technology and complete systems for bioanalytical applications in the life science area. Comprehensive ...
See moreOur purpose is to solve the toughest problems in life science by collaborating with the global scientific community - and through that, we aim to accelerate access to better health for people everywhere.
Jumpcode Genomics is improving the understanding of human biology by uncovering genomic mysteries. We are empowering scientists to advance the field of genomic research and discover unbiased data insights by increasing sensitivity and access to new sample types and broad ...
See moreAs the scientific community races to solve this evolving global health crisis, Twist Bioscience is proud to carry on as an active partner for all of your research needs. Twist's unique silicon-based DNA writing platform allows for the rapid development of NGS panels for viral ...
See moreDr. Svetlana Y. Folimonova received her PhD in Microbiology from Moscow State University, Moscow, Russia. She held a postdoctoral position at the S. R. Noble Foundation, Ardmore, Oklahoma and a postdoctoral position at the University of Florida, Citrus Research and Education ...
See moreDr. Juliet Morrison is an Assistant Professor at the University of California Riverside. Her research combines immunological and virological methods with computational analysis to address questions at the host-pathogen interface. A major interest of the Morrison Lab is ...
See moreDr. K. Leigh Greathouse is an Assistant Professor at Baylor University with appointments in Biology and Nutrition. Her background spands the fields of cancer biology, epidemiology, and nutrition. She recived her Ph.D. from the University of Texas and M.D. Anderson Cancer Center ...
See moreDr. O'Hara has developed cutting edge next-gen sequencing-based technology for hospitals and spent five years commercializing this technology. She has led unprecedented, large-scale metagenomics work characterizing the microbiome of ambulances across the US, hospital ...
See moreStephen S. Morse, Ph.D., is Professor of Epidemiology at the Columbia University Mailman School of Public Health, where he also serves as Director of the Infectious Disease Epidemiology certificate and as chair of the Columbia University Institutional Biosafety Committee (IBC) ...
See moreMatt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...
See moreDorottya earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary. Holding postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University, she has 10+ years of experience in translational medicine ...
See moreJonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...
See moreMeredith Ashby is the Director of Market Strategy for Microbial Genomics, Cancer and Immunology at Pacific Biosciences. She completed her Ph.D. at Caltech mapping the gene regulatory networks that direct sea urchin development just as the sea urchin genome was being sequenced ...
See moreDr. Roossinck received a PhD in 1986 from the University of Colorado School of Medicine in Microbiology and Immunology, studying Hepatitis B virus, on an National Institutes of Health fellowship. Following a postdoctoral fellowship at Cornell University, where she began studying ...
See moreDr. Ehrlich is Professor of Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery at Drexel University College of Medicine (DUCoM) in Philadelphia, PA, USA. He also directs: the Center for Genomic Sciences (CGS); the Center for Advanced Microbial Processing ...
See moreDr. Fernandez-Sesma is currently a professor with tenure in the department of Microbiology at Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY, USA. She is interested on the modulation of innate immunity by viruses of human health interests, such as dengue (DENV) ...
See moreJennifer M. Fettweis, Ph.D. is the founder and director of the Research Alliance for Microbiome Science (RAMS) Registry and assistant professor in the Departments of Microbiology and Immunology and Obstetrics and Gynecology at Virginia Commonwealth University. From 2009-2019, she ...
See more